Skip to main content
Figure 6 | Journal of Hematology & Oncology

Figure 6

From: SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Figure 6

Immunoprecipitation and western-blot analysis of heterodimerization interaction by TW-37 between anti-apoptosis and pro-apoptosis Bcl-2 family proteins. WSU-FSCCL cells were treated with 1 or 2 μM of TW-37 for 24 hr, lysed and 300 μg of whole cell lysate was immunoprecipitated with anti-Bim followed by Western-Blot with anti-Mcl-1, anti-Bcl-XL, anti-Bim and anti β-actin.

Back to article page